ERBB2 and cancer: This type of cancer shows a major tendency toward early metastasis [46,47], and does not respond to hormonal chemotherapy, as it lacks the three main molecular targets, the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor (HER-2/Neu) [48,49,50].